title: Therapy-related acute nonlymphocytic leukemia of FAB type M4 or M5 with early onset and t(9;11) (p21;q23) or a normal karyotype: a separate entity?
authors.forename: J
authors.initials: J
authors.lastname: Pedersen-Bjergaard
authors.forename: P
authors.initials: P
authors.lastname: Philip
authors.forename: V
authors.initials: V
authors.lastname: Ravn
authors.forename: S W
authors.initials: SW
authors.lastname: Hansen
authors.forename: N I
authors.initials: NI
authors.lastname: Nissen
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007621:Karyotyping; D007948:Leukemia, Monocytic, Acute / Q000139:chemically induced*; D008297:Male; D011379:Prognosis; D014178:Translocation, Genetic